|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang N and Pati D: Sororin is a master
regulator of sister chromatid cohesion and separation. Cell Cycle.
11:2073–2083. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang N and Pati D: Handcuff for sisters:
A new model for sister chromatid cohesion. Cell Cycle. 8:399–402.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang N, Panigrahi AK, Mao Q and Pati D:
Interaction of Sororin protein with polo-like kinase 1 mediates
resolution of chromosomal arm cohesion. J Biol Chem.
286:41826–41837. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yeh CR, Hsu I, Song W, Chang H, Miyamoto
H, Xiao GQ, Li L and Yeh S: Fibroblast ERalpha promotes bladder
cancer invasion via increasing the CCL1 and IL-6 signals in the
tumor microenvironment. Am J Cancer Res. 5:1146–1157.
2015.PubMed/NCBI
|
|
7
|
Nguyen MH, Koinuma J, Ueda K, Ito T,
Tsuchiya E, Nakamura Y and Daigo Y: Phosphorylation and activation
of cell division cycle associated 5 by mitogen-activated protein
kinase play a crucial role in human lung carcinogenesis. Cancer
Res. 70:5337–in vivo5347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen H, Chen J, Zhao L, Song W, Xuan Z,
Chen J, Li Z, Song G, Hong L, Song P, et al: CDCA5, Transcribed by
E2F1, promotes oncogenesis by enhancing cell proliferation and
inhibiting apoptosis via the AKT pathway in hepatocellular
carcinoma. J Cancer. 10:1846–1854. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen Z, Yu X, Zheng Y, Lai X, Li J, Hong
Y, Zhang H, Chen C, Su Z and Guo R: CDCA5 regulates proliferation
in hepatocellular carcinoma and has potential as a negative
prognostic marker. OncoTargets Ther. 11:891–901. 2018. View Article : Google Scholar
|
|
10
|
Shen A, Liu L, Chen H, Qi F, Huang Y, Lin
J, Sferra TJ, Sankararaman S, Wei L, Chu J, et al: Cell division
cycle associated 5 promotes colorectal cancer progression by
activating the ERK signaling pathway. Oncogenesis. 8:192019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang L, Tang H, Thayanithy V, Subramanian
S, Oberg AL, Cunningham JM, Cerhan JR, Steer CJ and Thibodeau SN:
Gene networks and microRNAs implicated in aggressive prostate
cancer. Cancer Res. 69:9490–9497. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li HY, Jin N, Han YP and Jin XF: Pathway
crosstalk analysis in prostate cancer based on protein-protein
network data. Neoplasma. 64:22–31. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tolkach Y, Merseburger A, Herrmann T,
Kuczyk M, Serth J and Imkamp F: Signatures of adverse pathological
features, androgen insensitivity and metastatic potential in
prostate cancer. Anticancer Res. 35:5443–5451. 2015.PubMed/NCBI
|
|
14
|
Burotto M, Chiou VL, Lee JM and Kohn EC:
The MAPK pathway across different malignancies: A new perspective.
Cancer. 120:3446–3456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim EK and Choi EJ: Compromised MAPK
signaling in human diseases: An update. Arch Toxicol. 89:867–882.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bolden A, Bernard L, Jones D, Akinyeke T
and Stewart LV: The PPAR gamma agonist troglitazone regulates Erk
1/2 phosphorylation via a PPARgamma-independent, MEK-dependent
pathway in human prostate cancer cells. PPAR Res.
929052:20122012.
|
|
17
|
Caraglia M, Marra M, Leonetti C, Meo G,
D'Alessandro AM, Baldi A, Santini D, Tonini G, Bertieri R, Zupi G,
et al: R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on
inhibition of prostate cancer proliferation is paralleled by
Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation. J
Cell Physiol. 211:533–543. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Xia C, Pu M, Dai B, Yang X, Shang
R, Yang Z, Zhang R, Tao K and Dou K: Silencing of CDCA5 inhibits
cancer progression and serves as a prognostic biomarker for
hepatocellular carcinoma. Oncol Rep. 40:1875–1884. 2018.PubMed/NCBI
|
|
19
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45((W1)):
W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cooper LA, Demicco EG, Saltz JH, Powell
RT, Rao A and Lazar AJ: PanCancer insights from The Cancer Genome
Atlas: The pathologist's perspective. J Pathol. 244:512–524. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)). Methods Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shen T, Li Y, Zhu S, Yu J, Zhang B, Chen
X, Zhang Z, Ma Y, Niu Y and Shang Z: YAP1 plays a key role of the
conversion of normal fibroblasts into cancer-associated fibroblasts
that contribute to prostate cancer progression. J Exp Clin Cancer
Res. 39:362020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bai L, Ren Y and Cui T: Overexpression of
CDCA5, KIF4A, TPX2, and FOXM1 coregulated cell cycle
and promoted hepatocellular carcinoma development. J Comput Biol.
27:965–974. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu B, Wang N, Wang X, Tong N, Shao N, Tao
J, Li P, Niu X, Feng N, Zhang L, et al: MiR-146a suppresses tumor
growth and progression by targeting EGFR pathway and in a
p-ERK-dependent manner in castration-resistant prostate cancer.
Prostate. 72:1171–1178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lopez-Lazaro M: The stem cell division
theory of cancer. Crit Rev Oncol Hematol. 123:95–113. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boeynaems S, Tompa P and Van Den Bosch L:
Phasing in on the cell cycle. Cell Div. 13:12018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang YC, Chang KC, Lin BW, Lee JC, Lai CH,
Lin LJ, Yen Y, Lin CS, Yang SJ, Lin PC, et al: The EGF/hnRNP Q1
axis is involved in tumorigenesis via the regulation of cell
cycle-related genes. Exp Mol Med. 50:1–14. 2018. View Article : Google Scholar
|
|
28
|
Lu J, Lin JX, Zhang PY, Sun YQ, Li P, Xie
JW, Wang JB, Chen QY, Cao LL, Lin Y, et al: CDK5 suppresses the
metastasis of gastric cancer cells by interacting with and
regulating PP2A. Oncol Rep. 41:779–788. 2019.PubMed/NCBI
|
|
29
|
Zhang Z, Shen M and Zhou G: Upregulation
of CDCA5 promotes gastric cancer malignant progression via
influencing cyclin E1. Biochem Biophys Res Commun. 496:482–489.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schmitz J, Watrin E, Lenart P, Mechtler K
and Peters JM: Sororin is required for stable binding of cohesin to
chromatin and for sister chromatid cohesion in interphase. Curr
Biol. 17:630–636. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nishiyama T, Ladurner R, Schmitz J, Kreidl
E, Schleiffer A, Bhaskara V, Bando M, Shirahige K, Hyman AA,
Mechtler K, et al: Sororin mediates sister chromatid cohesion by
antagonizing Wapl. Cell. 143:737–749. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rankin S, Ayad NG and Kirschner MW:
Sororin, a substrate of the anaphase-promoting complex, is required
for sister chromatid cohesion in vertebrates. Mol Cell. 18:185–200.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Feng W, Cai D, Zhang B, Lou G and Zou X:
Combination of HDAC inhibitor TSA and silibinin induces cell cycle
arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in
pancreatic cancer cells. Biomed Pharmacother. 74:257–264. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li P, Jia YF, Ma XL, et al: DEC2
suppresses tumor proliferation and metastasis by regulating
ERK/NF-kappaB pathway in gastric cancer. Am J Cancer Res.
6:1741–1757. 2016.PubMed/NCBI
|
|
35
|
Zhang L, Mao Y, Mao Q, Fan W, Xu L, Chen
Y, Xu L and Wang J: FLOT1 promotes tumor development, induces
epithelial-mesenchymal transition, and modulates the cell cycle by
regulating the Erk/Akt signaling pathway in lung adenocarcinoma.
Thorac Cancer. 10:909–917. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li ZH, Li L, Kang LP and Wang Y:
MicroRNA-92a promotes tumor growth and suppresses immune function
through activation of MAPK/ERK signaling pathway by inhibiting PTEN
in mice bearing U14 cervical cancer. Cancer Med. 7:3118–3131. 2018.
View Article : Google Scholar
|
|
37
|
Wang S, Huang X, Li Y, Lao H, Zhang Y,
Dong H, Xu W, Li JL and Li M: RN181 suppresses hepatocellular
carcinoma growth by inhibition of the ERK/MAPK pathway. Hepatology.
53:1932–1942. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mu X, Shi W, Xu Y, Xu C, Zhao T, Geng B,
Yang J, Pan J, Hu S, Zhang C, et al: Tumor-derived lactate induces
M2 macrophage polarization via the activation of the ERK/STAT3
signaling pathway in breast cancer. Cell Cycle. 17:428–438. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kumari G and Mahalingam S: Extracellular
signal-regulated kinase 2 (ERK-2) mediated phosphorylation
regulates nucleo-cytoplasmic shuttling and cell growth control of
Ras-associated tumor suppressor protein, RASSF2. Exp Cell Res.
315:2775–2790. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang Y, Zhang GL, Sun X, Cao KX, Shang
YW, Gong MX, Ma C, Nan N, Li JP, Yu MW, et al: Gubenyiliu II
inhibits breast tumor growth and metastasis associated with
decreased heparanase expression and phosphorylation of ERK and AKT
pathways. Molecules. 22:7872017.doi: 10.3390/molecules22050787.
View Article : Google Scholar
|
|
41
|
Tian Y, Wu J, Chagas C, Du Y, Lyu H, He Y,
Qi S, Peng Y and Hu J: CDCA5 overexpression is an indicator of poor
prognosis in patients with hepatocellular carcinoma (HCC). BMC
Cancer. 18:11872018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fu G, Xu Z, Chen X, Pan H, Wang Y and Jin
B: CDCA5 functions as a tumor promoter in bladder cancer by
dysregulating mitochondria-mediated apoptosis, cell cycle
regulation and PI3k/AKT/mTOR pathway activation. J Cancer.
11:2408–2420. 2020. View Article : Google Scholar : PubMed/NCBI
|
